| Followers | 36 |
| Posts | 2283 |
| Boards Moderated | 0 |
| Alias Born | 10/18/2019 |
Friday, March 21, 2025 10:13:42 PM
Gary, we both also own AVXL and they certainly go to conferences while waiting on results. Nwbo has results they can talke about.
You speak of the 25 cent mark. Well over a year ago now we were over $1 per share and at that time I was hoping we would never again see sub $1 valuation and not have to see these quote with 6 places after the decimal. Also just FYI schwab quotes the 52 week low at 0.2614 an cnbc at 22 cents so they do not just show the closing low.
I hold as many shares or more as you and just hope do not see 14 cents again - I have bought more each time but will not again. We may have similar # of shares but I have way more # to get to that # of shares as I had a very large investment as of 2015 and 90% down on those shares.
Worse I talked many others to buy this as well, many do not want to speak to me anymore
I believed Linda powers a decade ago when she said they were on the home stretch. Only reason I think this may have a chance is Linda Liau, Robert Prins and other dedicated research physicians
I have talked with les Goldman and Dave innes dozens of times and management I just no longer trust. My nwbo investment has worked it way down in value compared to other holdings so now just consider it my lottery ticket
You speak of the 25 cent mark. Well over a year ago now we were over $1 per share and at that time I was hoping we would never again see sub $1 valuation and not have to see these quote with 6 places after the decimal. Also just FYI schwab quotes the 52 week low at 0.2614 an cnbc at 22 cents so they do not just show the closing low.
I hold as many shares or more as you and just hope do not see 14 cents again - I have bought more each time but will not again. We may have similar # of shares but I have way more # to get to that # of shares as I had a very large investment as of 2015 and 90% down on those shares.
Worse I talked many others to buy this as well, many do not want to speak to me anymore
I believed Linda powers a decade ago when she said they were on the home stretch. Only reason I think this may have a chance is Linda Liau, Robert Prins and other dedicated research physicians
I have talked with les Goldman and Dave innes dozens of times and management I just no longer trust. My nwbo investment has worked it way down in value compared to other holdings so now just consider it my lottery ticket
Recent NWBO News
- Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses • PR Newswire (US) • 07/08/2026 06:42:00 PM
- Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses • PR Newswire (US) • 07/08/2026 06:24:00 PM
- Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting • PR Newswire (US) • 07/02/2026 06:41:00 PM
- Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting • PR Newswire (US) • 07/02/2026 06:17:00 PM
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
